| Identification | More | [Name]
O-BENZYL-D-SERINE | [CAS]
10433-52-0 | [Synonyms]
D-Ser(bzl)
D-Ser-(Bzl)-OH
H-D-SER(BZL)-OH
D-SERINE(BZL)-OH
O-BENZYL-D-SERINE
D-SERINE BENZYL ETHER
O-(Phenylmethyl)-D-serine
O-Benzyl-D-serine, ≥98.0%
D-Serine,O-(phenylMethyl)-
O-Benzyl-D-serine
(R)-2-AMINO-3-BENZYLOXYPROPIONIC ACID
(R)-2-Amino-3-(benzyloxy)propanoic acid
(2R)-2-aMino-3-(benzyloxy)propanoic acid
(2R)-2-amino-3-(benzyloxy)propionic acid
(2R)-2-amino-3-(phenylmethoxy)propanoic acid
(2R)-2-azanyl-3-(phenylmethoxy)propanoic acid
O-Benzyl-D-serine≥ 99.9% (HPLC, Chiral purity)
(R)-2-Amino-3-Benzyloxypropionic acid,O-Benzyl-D-serine
propanoic acid [4-(2-amino-9-purinyl)-2-(1-oxopropoxymethyl)butyl] ester | [EINECS(EC#)]
233-916-6 | [Molecular Formula]
C10H13NO3 | [MDL Number]
MFCD00065936 | [Molecular Weight]
195.22 | [MOL File]
10433-52-0.mol |
| Chemical Properties | Back Directory | [Melting point ]
~227 °C (dec.) | [Boiling point ]
359.1±37.0 °C(Predicted) | [density ]
1.217 | [storage temp. ]
Store at 0-5°C | [form ]
powder to crystal | [pka]
2.10±0.10(Predicted) | [color ]
White to Almost white | [optical activity]
[α]20/D 22±2°, c = 2% in acetic acid: water (4:1) (+ 1 Eq HCl) | [BRN ]
2649409 | [InChI]
InChI=1S/C10H13NO3/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m1/s1 | [InChIKey]
IDGQXGPQOGUGIX-SECBINFHSA-N | [SMILES]
C(O)(=O)[C@@H](COCC1=CC=CC=C1)N | [CAS DataBase Reference]
10433-52-0(CAS DataBase Reference) |
| Safety Data | Back Directory | [Safety Statements ]
S22:Do not breathe dust .
S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [HS Code ]
2922500090 |
| Hazard Information | Back Directory | [Chemical Properties]
White to off-white powder | [Uses]
O-Benzyl-D-serine has been shown to have been efficiently converted from D-5-monosubstitued hydatoin by E.coli thus revealing three co-expressed genes encoding hydantoin racemase, D-hydantoinase and N-carbamoyl-D-amino acid amidohydrolase. | [Definition]
O-Benzyl-D-serine is a serine derivative.
| [reaction suitability]
reaction type: solution phase peptide synthesis |
|
|